Study details
Enrolling now
Melatonin Trial to Prevent Kidney Injury
Rutgers, The State University of New Jersey
NCT IDNCT05084196ClinicalTrials.gov data as of Apr 2026
Phase
Phase 3
Target enrollment
300
Study length
about 4.6 years
Ages
18–75
Locations
2 sites in NJ
What this study is about
This trial is testing whether melatonin can help prevent kidney problems caused by certain antibiotics in hospitalized adults. Participants will receive either melatonin or a placebo capsule for 1670 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Melatonin
- 2.Take Placebo Capsule
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
melatonin (Hormone supplement; regulates sleep-wake cycle)
Drug routes
oral (Disintegrating Oral Tablet)
Body systems
Renal